NPTX2 and Alzheimer disease: Notably, this reduction is not observed in individuals who exhibit AD pathology but remained cognitively intact until death—commonly referred to as “asymptomatic AD” [4] or “high pathology controls” [5, 6]—suggesting that NPTX2 expression may represent a resilience factor for preserved cognition.